The Latest Breaking News from Disease

The European Commission has approved Horizon Therapeutics plc's (NASDAQ:HZNP) Uplizna (inebilizumab) as monotherapy for neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 immunoglobulin G seropositive (AQP4-IgG+). NMOSD is an autoimmune disease that attacks the optic nerve, spinal cord, brain, and brain stem. In the N-MOmentum pivotal clinical trial, Uplizna demonstrated a significant reduction…

It’s time, writes Abbey Lissaman, for doctors and researchers to focus on a debilitating health issue that affects 10 percent of women worldwide

Brave Grace MacMillan spent 28 days in hospital fighting off an illness which saw her immune system attack her healthy nerves.

Experts call on ministers to tackle chronic staff shortages, with delays worsened by pandemic

The number of patients receiving treatment for the disease has also risen

The 32-year-old will now honour his late dad by taking on epic challenge in aid of the British Heart Foundation

Australia’s peak body for GPs says there is a lack of awareness about treatments, which if taken early can prevent severe disease

The number of patients receiving treatment for the disease has also risen.

AGRA: As many as 184 people were diagnosed with malaria at health checkup camps organised last month across Kasganj district. However, so far, the health department has not made any arrangement for anti-larvae spraying to prevent the vector-borne disease from spreading.